SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹24 Cr | ₹26 Cr | ₹10 Cr | ₹6.79 Cr |
What is the latest Total Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹26 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.79 Cr |
How is Total Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | -6.65 | |
| Mar2024 | ₹26 Cr | 149.96 | |
| Mar2020 | ₹10 Cr | 52.89 | |
| Mar2019 | ₹6.79 Cr | - | |
Compare Total Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹515.9 Cr | -7.3% | -7.5% | -40.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,905.0 Cr | -5.2% | -7.6% | -8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,357.0 Cr | -5.6% | -7.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,788.0 Cr | -0.6% | 4.8% | 25% | Stock Analytics | |
| CIPLA | ₹110,628.0 Cr | -4.5% | -9.7% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,441.5 Cr | -2.6% | -9.7% | -10.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -7.3% |
-7.5% |
-40.3% |
| SENSEX | -2.1% |
-3% |
6.8% |
You may also like the below Video Courses